Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy.
Belkouchi Y, Talbot H, Lassau N, Lawrance L, Farhane S, Feki-Mkaouar R, Hadchiti J, Dawi L, Vibert J, Cournède PH, Cousteix C, Mazza C, Kind M, Italiano A, Marabelle A, Ammari S, Champiat S.
Belkouchi Y, et al. Among authors: cournede ph.
Clin Cancer Res. 2023 Apr 14;29(8):1528-1534. doi: 10.1158/1078-0432.CCR-22-0890.
Clin Cancer Res. 2023.
PMID: 36719966